Accéder au contenu
Merck
  • [Metabolic and neurochemical effects of nicergoline on the central nervous system. A review of the experimental studies (author's transl)].

[Metabolic and neurochemical effects of nicergoline on the central nervous system. A review of the experimental studies (author's transl)].

Arzneimittel-Forschung (1979-01-01)
A Moretti
PMID395953
RÉSUMÉ

The effects of 10-methoxy-1,6-dimethyl-ergoline-8 beta-methanol(5-bromonicotinate) (nicergoline, Sermion) on the energy metabolism in the animal CNS during and after cerebral hypoxia and ischemia have been studied by various authors by different methodological approaches. For this purpose both electrophysiological (EEG and cortically evoked potentials) and neurochemical parameters (adenylates, creatinphosphate and some intermediates of glycolysis and Krebs cycle) were analysed in dogs and cats. These studies concordantly show that nicergoline exerts a favourable activity during the post-hypoxic and post-ischemic period. In fact the recovery of the electrophysiological and neurochemical parameters is always more rapid in nicergoline-treated animals than in controls. The effects of nicergoline on the EEG pattern, on the energy potential and citrate concentration are particularly interesting.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Supelco
Nicergoline, analytical standard, for drug analysis
Nicergoline, European Pharmacopoeia (EP) Reference Standard
Nicergoline for system suitability, European Pharmacopoeia (EP) Reference Standard
Nicergoline for peak identification, European Pharmacopoeia (EP) Reference Standard